Rheumatoid arthritis and accelerated atherogenesis.
Gonzalez-Juanatey
Carlos
C
Gonzalez-Gay
Miguel A
MA
D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000209:etiology* / Q000503:physiopathology; D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology; D001327:Autoimmune Diseases / Q000150:complications* / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology; D004730:Endothelium, Vascular / Q000503:physiopathology; D006684:HLA-DR Antigens / Q000032:analysis; D059811:HLA-DRB1 Chains; D006801:Humans; D007249:Inflammation; D000069285:Infliximab; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000502:physiology; D014664:Vasodilation
D000911:Antibodies, Monoclonal; D006684:HLA-DR Antigens; D059811:HLA-DRB1 Chains; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab